Document is current

Any future updates will be listed below

Tivozanib monotherapy outperforms combination therapy in post-ICI RCC

Crossref DOI link: https://doi.org/10.1038/s41585-024-00971-y

Published Online: 2024-11-11

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark